v3.26.1
Unaudited Condensed Consolidated Statements of Change in Stockholders’ Deficit - USD ($)
Preferred stock
Common stock
Additional paid in capital
Accumulated Deficit
Accumulated other comprehensive loss
Total
Balance at Dec. 31, 2023   $ 74 $ 1,528,926 $ (8,247,862) $ (1,075) $ (6,719,937)
Balance (in Shares) at Dec. 31, 2023 [1] 742,416        
Issuance of shares upon the reverse recapitalization   $ 13   (2,833,487)   (2,833,474)
Issuance of shares upon the reverse recapitalization (in Shares) [1]   134,476        
Additional shares issued in connection with reverse recapitalization   $ 1 (1)      
Additional shares issued in connection with reverse recapitalization (in Shares) [1]   5,114        
Stock compensation expense     171,897     171,897
Stock compensation expense (in Shares) [1]   2,091        
Shares to be issued for stock compensation (in Shares) [1]   (2,091)        
Foreign currency translation adjustments         50 50
Net loss       (2,306,806)   (2,306,806)
Balance at Mar. 31, 2024   $ 88 1,700,822 (13,388,155) (1,025) (11,688,270)
Balance (in Shares) at Mar. 31, 2024 [1] 882,006        
Balance at Dec. 31, 2023   $ 74 1,528,926 (8,247,862) (1,075) (6,719,937)
Balance (in Shares) at Dec. 31, 2023 [1] 742,416        
Net loss           (6,825,461)
Balance at Sep. 30, 2024   $ 107 5,942,449 (17,906,810) (1,143) (11,965,397)
Balance (in Shares) at Sep. 30, 2024 [1]   1,059,673        
Balance at Mar. 31, 2024   $ 88 1,700,822 (13,388,155) (1,025) (11,688,270)
Balance (in Shares) at Mar. 31, 2024 [1] 882,006        
Stock compensation expense   $ 1 195,907     195,908
Stock compensation expense (in Shares) [1]   5,416        
Shares to be issued for stock compensation (in Shares) [1]   (416)        
Foreign currency translation adjustments         (83) (83)
Net loss       (1,768,319)   (1,768,319)
Balance at Jun. 30, 2024   $ 89 1,896,729 (15,156,474) (1,108) (13,260,764)
Balance (in Shares) at Jun. 30, 2024 [1] 887,006        
Stock compensation expense     848,075     848,075
Stock compensation expense (in Shares) [1]   2,827        
Shares and warrants issued through public offering   $ 17 1,003,983     1,004,000
Shares and warrants issued through public offering (in Shares) [1]   166,667        
Shares and warrants issued through private placement   $ 1 58,089     58,090
Shares and warrants issued through private placement (in Shares) [1]   6,000        
Forgiveness of related party’s debt     2,135,573     2,135,573
Shares to be issued for stock compensation (in Shares) [1]   (2,827)        
Foreign currency translation adjustments         (35) (35)
Net loss       (2,750,336)   (2,750,336)
Balance at Sep. 30, 2024   $ 107 5,942,449 (17,906,810) (1,143) (11,965,397)
Balance (in Shares) at Sep. 30, 2024 [1]   1,059,673        
Balance at Dec. 31, 2024 $ 246 10,396,274 (24,734,689) (981) (14,339,150)
Balance (in Shares) at Dec. 31, 2024 2,445,364 [1]        
Stock compensation expense $ 8 84,928 84,936
Stock compensation expense (in Shares) [1]   84,091        
Shares to be issued for stock compensation (in Shares) [1]   (834)        
Shares issued through warrants exercises $ 184 865,239 865,423
Shares issued through warrants exercises (in Shares) [1]   1,839,023        
Shares issued through debt-to-equity conversion $ 57 (57)
Shares issued through debt-to-equity conversion (in Shares) [1]   568,182        
Foreign currency translation adjustments 394 394
Net loss (2,019,811) (2,019,811)
Balance at Mar. 31, 2025 $ 495 11,346,384 (26,754,500) (587) (15,408,208)
Balance (in Shares) at Mar. 31, 2025 4,935,826 [1]        
Balance at Dec. 31, 2024 $ 246 10,396,274 (24,734,689) (981) (14,339,150)
Balance (in Shares) at Dec. 31, 2024 2,445,364 [1]        
Net loss           (5,997,578)
Balance at Sep. 30, 2025 $ 1 $ 1,347 21,386,370 (30,747,872) (667) (9,360,821)
Balance (in Shares) at Sep. 30, 2025 14,500 13,453,190 [1]        
Balance at Mar. 31, 2025 $ 495 11,346,384 (26,754,500) (587) (15,408,208)
Balance (in Shares) at Mar. 31, 2025 4,935,826 [1]        
Stock compensation expense     60,957     60,957
Shares issued through convertible notes conversion   $ 258 147,617     147,875
Shares issued through convertible notes conversion (in Shares) [1]   2,576,943        
Foreign currency translation adjustments         (135) (135)
Net loss       (1,770,937)   (1,770,937)
Balance at Jun. 30, 2025   $ 753 11,554,958 (28,525,437) (722) (16,970,448)
Balance (in Shares) at Jun. 30, 2025 [1] 7,512,769        
Stock compensation expense   $ 44 84,102     84,146
Stock compensation expense (in Shares) [1]   439,833        
Shares issued through convertible notes conversion   $ 387 109,200     109,587
Shares issued through convertible notes conversion (in Shares) [1]   3,867,938        
Preferred stock issued for asset acquisition $ 1   9,415,633     9,415,634
Preferred stock issued for asset acquisition (in Shares) 14,500          
Shares issued under equity line of credit   $ 143 145,666     145,809
Shares issued under equity line of credit (in Shares) [1]   1,432,650        
Shares issued for purchase of convertible note   $ 20 76,811     76,831
Shares issued for purchase of convertible note (in Shares) [1]   200,000        
Cumulative dividend for Series A and D preferred stock       (15,605)   (15,605)
Foreign currency translation adjustments         55 55
Net loss       (2,206,830)   (2,206,830)
Balance at Sep. 30, 2025 $ 1 $ 1,347 $ 21,386,370 $ (30,747,872) $ (667) $ (9,360,821)
Balance (in Shares) at Sep. 30, 2025 14,500 13,453,190 [1]        
[1] Giving retroactive effect to reverse recapitalization effected on March 11, 2024 and the 1-for-30 reverse stock split effected on November 21, 2024